A multiyear co-innovation lab ties Eli Lilly’s drug pipeline to Nvidia’s next hardware cycle, betting faster discovery comes ...
24/7 Wall St. on MSN
Eli Lilly and Nvidia make $1 billion AI bet to revolutionize pharma’s future
Quick Read Eli Lilly (LLY) and Nvidia (NVDA) will invest up to $1B over five years in an AI drug discovery lab. AI could ...
South San Francisco is poised to become an even hotter address for biotech and chip companies. Nvidia and Eli Lilly said ...
insights from industryBernd GleixnerDivision President AutomationBruker Biopsin News Medical speaks to Bernd Gleixner, Division President Automation at Bruker Biospin, about the future of lab ...
BUFFALO, N.Y. — University at Buffalo researcher Murali Ramanathan, PhD, has used artificial intelligence (AI) since its nascent days while exploring possible treatments for multiple sclerosis (MS) ...
“In labs around the world, scientific teams are applying the software-as-a-service model to generate more data than ever before. And while that data has enormous potential to drive innovation, it’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback